Investors

Outlook and guidance

Guidance for 2024 19 December, 2024):

Biohit’s 2024 revenue will be 14.1-14.4 million EUR (growth from 2023 7.8-10.1%) and operating profit percentage 16-18%.

Previous guidance for 2024 (issued February 14, 2024, reissued August 7, 2024):**

In line with the financial targets we set in our strategy, we expect our revenue to rise to EUR 15.1-15.7 million in 2024 and our operating profit percentage to be at least 10.